Nanocarriers Mediated Cutaneous Drug Delivery

The cutaneous drug delivery represents an attractive option for the management of skin diseases. However, the skin has a very complex morphological structure, although the skin barrier is disrupted in some of dermatological diseases. Therefore, to safely overcome the skin barrier and to deliver drugs across the skin efficiently is still remain as a challenge in the management of dermatological diseases. The nanocarrier mediated cutaneous delivery appears to offer a hope to provide targeting potential of the drugs into specific sites of the skin with minimizing side effects. This review highlights, the human structure and diseased skin barrier, and possible therapeutic outcomes of nanocarrier based drug delivery in the treatment of skin diseases due to their skin transport and follicular targeting mechanisms, and summarizes recent studies in which polymer, lipid and surfactant based nanocarriers of drugs used in the skin diseases. Continue on Nanocarriers Mediated Cutaneous Drug Delivery

Author links open overlay panelSevgi Güngör, Emine Kahraman
European Journal of Pharmaceutical Sciences
Available online 8 November 2020, 105638
https://doi.org/10.1016/j.ejps.2020.105638

 

You might also like